Exelixis
EXEL
#1771
Rank
A$17.70 B
Marketcap
A$65.76
Share price
-3.26%
Change (1 day)
11.73%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company